Literature DB >> 8590522

Pharmacobezoar: an evolving new entity.

P E Stack1, E Thomas.   

Abstract

Pharmacobezoars, bezoars comprised of medications, are unusual entities. Medications reported to cause bezoars include aluminum hydroxide gel, enteric-coated aspirin, sucralfate, guar gum, cholestyramine, enteral feeding formulas, psyllium preparations, nifedipine XL, and meprobamate. They most often occur, as do bezoars of any type, in a background of altered motility or anatomy of the gastrointestinal tract. Bowel hypoactivity, dehydration, and concomitant use of anticholinergics and narcotis appear to contribute to the propensity for bezoar formation by aluminum hydroxide gel and Isocal. The hygroscopic properties of psyllium and guar gum appear to contribute to their propensity to form bezoars. Insolubility of the carrying vehicle of enteric-coated aspirin and nifedipine is the setting in which these medications form bezoars. In contrast to nonmedication bezoars, pharmacobezoars may produce additional symptoms, those related to the release of their active ingredients. In patients with suspected gastrointestinal tract emptying problems, whether esophageal, gastric, small bowel, or colonic, the astute clinician should consider pharmacobezoar in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590522     DOI: 10.1159/000171515

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  16 in total

1.  Rectal obstruction by a giant pharmacobezoar composed of magnesium oxide: report of a case.

Authors:  Yoshinobu Shigekawa; Yasuhito Kobayashi; Takashi Higashiguchi; Tohru Nasu; Motoki Yamamoto; Minoru Ochiai; Takeshi Tsuji; Hiroki Yamaue
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

2.  Unusual acute formed gastric bezoars due to plaster ingestion successfully treated by gastric irrigation: report of two cases.

Authors:  Morteza Sanei Taheri; Seyyed Mohammad Kharrazi; Hamid Reza Haghighatkhah; Yashar Moharamzad
Journal:  Emerg Radiol       Date:  2007-11-29

3.  Gastric electrical stimulation for gastroparesis: a goal greatly pursued, but not yet attained.

Authors:  Mauro Bortolotti
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

Review 4.  Review of the diagnosis and management of gastrointestinal bezoars.

Authors:  Masaya Iwamuro; Hiroyuki Okada; Kazuhiro Matsueda; Tomoki Inaba; Chiaki Kusumoto; Atsushi Imagawa; Kazuhide Yamamoto
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

5.  Gastrointestinal safety of an extended-release, nondeformable, oral dosage form (OROS: a retrospective study.

Authors:  Dorsey M Bass; Mary Prevo; Deborah S Waxman
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Catastrophic gastric rupture in a horse secondary to psyllium pharmacobezoars.

Authors:  Thomas C Bergstrom; R Russell Sakai; Jorge E Nieto
Journal:  Can Vet J       Date:  2018-03       Impact factor: 1.008

7.  Small bowel obstruction due to inflammation secondary to ingested bone.

Authors:  D Bandyopadhyay; C S Orgles; E P Dewar
Journal:  Emerg Radiol       Date:  2005-08-31

8.  Severe neonatal holocarboxylase synthetase deficiency in west african siblings.

Authors:  Mauricio De Castro; Dina J Zand; Uta Lichter-Konecki; Brian Kirmse
Journal:  JIMD Rep       Date:  2015-02-18

Review 9.  MDCT imaging of the stomach: advances and applications.

Authors:  Prashant Nagpal; Anjali Prakash; Gaurav Pradhan; Aditi Vidholia; Nishant Nagpal; Sachin S Saboo; David M Kuehn; Ashish Khandelwal
Journal:  Br J Radiol       Date:  2016-12-08       Impact factor: 3.039

Review 10.  Endoscopic management of a new entity-plastobezoar: a case report and review of literature.

Authors:  S P Misra; Manisha Dwivedi; Vatsala Misra
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.